Mindpeak
49 employees on LinkedIn · 8 known investors
Mindpeak develops AI-powered diagnostic software for cancer pathology, translating complex tissue data into clinical insights to support treatment decisions. The company serves pathologists and clinical institutions working in cancer diagnostics and drug development.
Investors · 8
FraserBerlin
Nina CapitalBarcelona · $215K – $1.6M
AI Fundreported · 2 sourcesMountain View · $100K – $1M
European Innovation Council Fundreported · 2 sources
ZEISS Venturesreported · 2 sourcesOberkochen
Also in the syndicate · 3
IFB Innovationsstarter GmbHleadInnoVentureFondsleadInnoVentureFundlead
Funding
SEC filings, press & company announcements$30.6M disclosed across 2 rounds · 2024
- $15.3MSeries AOct 2024 · 2 sources
IFB Innovationsstarter GmbH (lead), InnoVentureFonds (lead), InnoVentureFund (lead), ZEISS Ventures (lead), AI.FUND, European Innovation Council Fund
Source ↗ - $15.3Mseries ASep 2024 · 2 sources
InnoVentureFund (lead), Zeiss Ventures (lead), AI.FUND, European Innovation Council Fund
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Mindpeak do?
- Mindpeak develops AI-powered diagnostic software for cancer pathology, translating complex tissue data into clinical insights to support treatment decisions. The company serves pathologists and clinical institutions working in cancer diagnostics and drug development.
- Who are Mindpeak's investors?
- Mindpeak's investors include Fraser, Nina Capital, AI Fund, European Innovation Council Fund, ZEISS Ventures.
- How much funding has Mindpeak raised?
- Mindpeak has disclosed $30.6M raised across 2 rounds.